Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary

M Ellen Kuenzig^{1

2}, Joseph W Windsor³, Lisa Barrett⁴, Charles N Bernstein^{5

6}, Alain Bitton⁷, Matthew W Carroll⁸, Usha Chauhan⁹, Stephanie Coward^{3

10}, Sharyle Fowler¹¹, Jean-Eric Ghia¹², Rose Geist¹³, Deanna L Gibson¹⁴, Lesley A Graff^{6

15}, Anne M Griffiths^{1

2

16

17}, James Guoxian Huang¹, Jennifer L Jones⁴, Reena Khanna¹⁸, Peter L Lakatos^{7

19}, Kate Lee²⁰, David R Mack²¹, John K Marshall⁹, Mariam S Mukhtar²², Sanjay K Murthy²³, Geoffrey C Nguyen²⁴, Remo Panaccione²⁵, Cynthia H Seow^{3

10}, Harminder Singh^{5

6}, Parul Tandon²⁶, Laura E Targownik²⁶, Sandra Zelinsky³, Eric I Benchimol^{1

2

16

17}, Gilaad G Kaplan^{3

10}

Affiliations

¹ SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada.
² Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada.
³ Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
⁴ Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
⁵ Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
⁶ University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, Canada.
⁷ Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
⁸ Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
⁹ Hamilton Health Science, Department of Medicine and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
¹⁰ Departments of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
¹¹ Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
¹² Department of Immunology and Internal Medicine section of Gastroenterology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba and University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, Winnipeg, Manitoba, Canada.
¹³ Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
¹⁴ Department of Biology, Faculty of Science; Department of Medicine, Faculty of Medicine, The University of British Columbia, Okanagan campus, Kelowna, British Columbia, Canada.
¹⁵ Department of Clinical Health Psychology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
¹⁶ ICES, Toronto, Ontario, Canada.
¹⁷ Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
¹⁸ London Health Sciences Centre-University Campus, Western University, London, Ontario, Canada.
¹⁹ 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
²⁰ Crohn's and Colitis Canada, Toronto, Ontario, Canada.
²¹ CHEO Inflammatory Bowel Disease Centre and Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.
²² Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
²³ The Ottawa Hospital IBD Centre, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
²⁴ Mount Sinai Hospital Inflammatory Bowel Disease Centre, University of Toronto, Toronto, Ontario, Canada.
²⁵ Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
²⁶ Division of Gastroenterology and Hepatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

PMID: 34755033
PMCID: PMC8570424
DOI: 10.1093/jcag/gwab027

Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary

M Ellen Kuenzig et al. J Can Assoc Gastroenterol. 2021.

. 2021 Nov 5;4(Suppl 2):S1-S9.

doi: 10.1093/jcag/gwab027. eCollection 2021 Dec.

Authors

Affiliations

¹ SickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada.
² Child Health Evaluative Sciences, SickKids Research Institute, Toronto, Ontario, Canada.
³ Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
⁴ Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
⁵ Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
⁶ University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, Canada.
⁷ Department of Medicine, McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
⁸ Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
⁹ Hamilton Health Science, Department of Medicine and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
¹⁰ Departments of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
¹¹ Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
¹² Department of Immunology and Internal Medicine section of Gastroenterology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba and University of Manitoba Inflammatory Bowel Disease Clinical and Research Centre, Winnipeg, Manitoba, Canada.
¹³ Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
¹⁴ Department of Biology, Faculty of Science; Department of Medicine, Faculty of Medicine, The University of British Columbia, Okanagan campus, Kelowna, British Columbia, Canada.
¹⁵ Department of Clinical Health Psychology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
¹⁶ ICES, Toronto, Ontario, Canada.
¹⁷ Department of Paediatrics and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
¹⁸ London Health Sciences Centre-University Campus, Western University, London, Ontario, Canada.
¹⁹ 1st Department of Medicine, Semmelweis University, Budapest, Hungary.
²⁰ Crohn's and Colitis Canada, Toronto, Ontario, Canada.
²¹ CHEO Inflammatory Bowel Disease Centre and Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada.
²² Department of Internal Medicine, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
²³ The Ottawa Hospital IBD Centre, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
²⁴ Mount Sinai Hospital Inflammatory Bowel Disease Centre, University of Toronto, Toronto, Ontario, Canada.
²⁵ Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.
²⁶ Division of Gastroenterology and Hepatology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

PMID: 34755033
PMCID: PMC8570424
DOI: 10.1093/jcag/gwab027

Abstract

Persons with inflammatory bowel disease (IBD) make up more than 0.75% of the Canadian population in 2021. Early in the COVID-19 pandemic, individuals with IBD, particularly those on immunosuppressive therapies, were concerned that their health status may place them at higher risk of contracting COVID-19 or experiencing more severe disease course if infected with SARS-CoV-2. In response, Crohn's and Colitis Canada developed the COVID-19 and IBD Taskforce in March 2020 to rapidly synthesize the evolving knowledge of COVID-19 as relevant to Canadians with IBD. The Taskforce communicated expert information directly to the Canadian IBD community through online tools and a webinar series. In order to understand the full impact of COVID-19 on the IBD community, Crohn's and Colitis Canada commissioned a policy report that was informed through a systematic literature review and synthesized across working groups along the following domains: Epidemiology, Children and Expectant Mothers with IBD, Seniors with IBD, Mental Health, Risk Factors and Medications, Vaccines, and Healthcare Delivery during the Pandemic and the Future Model of IBD Care. This report from Canadian physicians, researchers, and IBD community representatives highlights the physical, mental, and health systems impact of COVID-19 on the entire spectrum of the IBD community, including children, adolescents, adults, seniors, and pregnant people with IBD. This executive summary provides an overview of the crucial information from each of the chapters of the policy report, supplemented with additional information made available through Crohn's and Colitis Canada's webinar-based knowledge translation platform.

Keywords: Coronavirus; Crohn’s disease; SARS-CoV-2; Ulcerative colitis.

PubMed Disclaimer

Figures

See this image and copyright information in PMC

References

1. Coward S, Clement F, Benchimol EI, et al. Past and future burden of inflammatory bowel diseases based on modeling of population-based data. Gastroenterology 2019;156(5):1345–1353.e4. - PubMed
1. Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021;18(1):56–66. - PMC - PubMed
1. Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012;142(1):46–54.e42; quiz e30. - PubMed
1. Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21^st century: A systematic review of population-based studies. Lancet 2017;390(10114):2769–78. - PubMed
1. Benchimol EI, Bernstein CN, Bitton A, et al. The Impact of Inflammatory Bowel Disease in Canada 2018: A scientific report from the Canadian gastro-intestinal epidemiology consortium to Crohn’s and Colitis Canada. J Can Assoc Gastroenterol 2019;2(Suppl 1):1–5. - PMC - PubMed

LinkOut - more resources

Full Text Sources
- Europe PubMed Central
- PubMed Central
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary

Affiliations

Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Executive Summary

Authors

Affiliations

Abstract

Figures

References

LinkOut - more resources

Full Text Sources

Miscellaneous